Single-chain cd27-receptor agonist proteins
AssigneeApogenix AG
InventorsChristian GIEFFERS, Oliver HILL, Meinolf THIEMANN, Tim SCHNYDER
Life of this patent
Estimating the term…
Abstract
Provided herein are specific CD27 receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a CD27L-associated disease or disorder. The CD27 receptor agonist proteins provided herein comprise three soluble CD27L domains an and Fc fragment. The CD27 receptor agonist proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.
Claims19
A nucleic acid molecule encoding a cluster of differentiation 27 (CD27) receptor agonist protein, whereby said protein is a single-chain fusion polypeptide comprising:
- (i) a first soluble CD27L (CD27 ligand) domain,
- (ii) a first peptide linker having 3 to 8 amino acids,
- (iii) a second soluble CD27L domain,
- (iv) a second peptide linker having 3 to 8 amino acids,
- (v) a third soluble CD27L domain,
- (vi) a hinge-linker selected from the group consisting of SEQ ID NOs:
- 16 and 19-24, and
- (vii) an antibody Fc fragment consisting of the amino acid sequence of SEQ ID NO:
- 13 or amino acids 1-217 of SEQ ID NO:
- 13;
- wherein each of the soluble CD27L domains (i), (iii), and (v) comprises amino acids Asp56-Pro193 of SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.